Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai No 1 Pharmacy Co's EBIT per Share for the
three
months ended in Mar. 2026 was ¥0.14.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.47.
During the past 3 years, the average EBIT per Share Growth Rate was -66.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Shanghai No 1 Pharmacy Co's EBIT per Share or its related term are showing as below:
SHSE:600833'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -66.7 Med: 3.85 Max: 286
Current: -66.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shanghai No 1 Pharmacy Co was 286.00% per year. The lowest was -66.70% per year. And the median was 3.85% per year.
SHSE:600833's 3-Year EBIT Growth Rate is ranked worse than 97.9% of 525
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs SHSE:600833: -66.70
Shanghai No 1 Pharmacy Co (SHSE:600833) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Shanghai No 1 Pharmacy Co EBIT per Share Related Terms
Shanghai No 1 Pharmacy Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai No 1 Pharmacy Co (SHSE:600833) has a EBIT per Share of ¥0.47 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shanghai No 1 Pharmacy Co and its competitors. According to the industry distribution chart, Shanghai No 1 Pharmacy Co ranks #514 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 97.9%.
Is Shanghai No 1 Pharmacy Co's EBIT per Share too high?
Shanghai No 1 Pharmacy Co's current EBIT per Share is ¥0.47. Based on the distribution chart, Shanghai No 1 Pharmacy Co ranks #514 out of 525 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Shanghai No 1 Pharmacy Co has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai No 1 Pharmacy Co's EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Shanghai No 1 Pharmacy Co ranks #514 out of 525 companies for EBIT per Share. This places Shanghai No 1 Pharmacy Co in the lower half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shanghai No 1 Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai No 1 Pharmacy Co's current EBIT per Share is ¥0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai No 1 Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co (SHSE:600833) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥12.81, compared to a current price of ¥9.41 — trading 26.5% below its estimated fair value. The current EBIT per Share is ¥0.47. Shanghai No 1 Pharmacy Co's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Shanghai No 1 Pharmacy Co (SHSE:600833), the current EBIT per Share is ¥0.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai No 1 Pharmacy Co (SHSE:600833) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co stock appears to be undervalued.
The current stock price of ¥9.41 is trading 26.5% below its estimated GF Value™ of ¥12.81.
GuruFocus considers Shanghai No 1 Pharmacy Co to be Modestly Undervalued.
Key valuation signals for SHSE:600833:
EBIT per Share: ¥0.47
GF Value™: ¥12.81 vs. price of ¥9.41 (26.5% below fair value)
No single metric tells the full story. See the SHSE:600833 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai No 1 Pharmacy Co Ltd is engaged in pharmaceutical retail and wholesale in China. The company's product profile include Lei Shi Pearl Powder, Tongrentang Ejiao Powder, Wanshuntang Yangyin mouth fragrance mixture, and others. It also provides Nourishing health Nutrition, Medical instruments, Rehabilitation care, Contact lens, and others.
56GF Score
Get the complete analysis for SHSE:600833
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600833 has been successfully added to your 
